Related references
Note: Only part of the references are listed.Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices
Oscar Cano et al.
EUROPACE (2011)
Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial
Alan Cheng et al.
HEART RHYTHM (2011)
Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures Results From the REPLACE Registry
Jeanne E. Poole et al.
CIRCULATION (2010)
Risk of Hematoma Complications After Device Implant in the Clopidogrel Era
Ilana B. Kutinsky et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2010)
Do gender differences exist in pacemaker implantation?-results of an obligatory external quality control program
Bernd Nowak et al.
EUROPACE (2010)
Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey
Sami Pakarinen et al.
EUROPACE (2010)
Peri-procedural Anticoagulation and the Incidence of Haematoma Formation after Permanent Pacemaker Implantation in the Elderly
Vincent Chow et al.
HEART LUNG AND CIRCULATION (2010)
Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation
Imdad Ahmed et al.
HEART RHYTHM (2010)
Perioperative Management of Patients With Drug-Eluting Stents
Ali O. Abualsaud et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Chronic kidney disease is an independent predictor of pocket hematoma after pacemaker and defibrillator implantation
Imdad Ahmed et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2010)
Dual Antiplatelet Therapy and Heparin Bridging Significantly Increase the Risk of Bleeding Complications After Pacemaker or Implantable Cardioverter-Defibrillator Device Implantation
Christine Tompkins et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Perioperative Management of Anticoagulation during Device Implantation-The UK Perspective
Joseph de Bono et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2010)
Perioperative Management of Anticoagulation in Patients Undergoing Cardiac Rhythm Device Procedures: A Bridge to Nowhere?
Charles J. Love
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2010)
Is Antiarrhythmia Device Implantation Safe Under Dual Antiplatelet Therapy?
Henryk Dreger et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2010)
Cardiac Resynchronization Therapy Device Implantation in Patients with Therapeutic International Normalized Ratios
Hamid Ghanbari et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2010)
An Anatomic-Based Approach for the Placement of Implantable Loop Recorders
Blair P. Grubb et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2010)
The Relationship between Warfarin, Aspirin, and Clopidogrel Continuation in the Peri-procedural Period and the Incidence of Hematoma Formation after Device Implantation
Sergio Thal et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2010)
Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy Results of a prospective, two-centre registry
A. Przybylski et al.
NETHERLANDS HEART JOURNAL (2010)
Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin
Alex Tischenko et al.
AMERICAN HEART JOURNAL (2009)
Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents
Mark J. Eisenberg et al.
CIRCULATION (2009)
Gender Differences in Procedure-Related Adverse Events in Patients Receiving Implantable Cardioverter-Defibrillator Therapy
Pamela N. Peterson et al.
CIRCULATION (2009)
How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery
Helge Moellmann et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design
David Birnie et al.
CURRENT OPINION IN CARDIOLOGY (2009)
Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation
Min Cheng et al.
EUROPACE (2009)
Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial
Jose M. Tolosana et al.
EUROPEAN HEART JOURNAL (2009)
Perioperative management of antiplatelet agents in noncardiac surgery
Juan V. Llau et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2009)
Risk factors and time delay associated with cardiac device infections: Leiden device registry
J. C. Lekkerkerker et al.
HEART (2009)
Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada
Andrew D. Krahn et al.
HEART RHYTHM (2009)
Postoperative Low-Molecular-Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators
Marlene Robinson et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2009)
Temporal trends in permanent pacemaker implantation: A population-based study
Daniel Z. Uslan et al.
AMERICAN HEART JOURNAL (2008)
Risk of thromboembolism with short-term interruption of warfarin therapy
David A. Garcia et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Management of surgical patients receiving anticoagulation and antiplatelet agents
J. Thachil et al.
BRITISH JOURNAL OF SURGERY (2008)
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide
E. Jamula et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
History of electrical therapy for the heart
Richard Sutton et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2007)
Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association
Hugo Ector et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2007)
Incidence and predictors of in-hospital events after first implantation of pacemakers
J. W. M. van Eck et al.
EUROPACE (2007)
Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators - Results of a large prospective study
Didier Klug et al.
CIRCULATION (2007)
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial:: procedural success rate and safety
D. Gras et al.
EUROPACE (2007)
Post-operative use of heparin increases morbidity of pacemaker implantation
C. Marquie et al.
EUROPACE (2006)
Incidence and predictors of cardiac perforation after permanent pacemaker placement
S Mahapatra et al.
HEART RHYTHM (2005)
Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment
DJ Milic et al.
EUROPACE (2005)
Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy
MC Giudici et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2004)
Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery - Influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy
UKH Wiegand et al.
CHEST (2004)
Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients
AS Al-Khadra
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2003)
Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk
TG Phan et al.
ARCHIVES OF NEUROLOGY (2000)
A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation
GF Michaud et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
